Axsome Therapeutics, Inc. ($AXSM)
Filing Information
| Accession Number | 0001193125-26-207148 |
|---|---|
| Form Type | 4 |
| Filing Date | May 6, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
14,250
Total Value
$1,144,283.42
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | May 4, 2026 | Exercise/Conversion | 4,517 | $12.95 | $58,495.15 | 4,517 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 4, 2026 | Sale | 4,517 | $227.94 | $1,029,604.98 | 0 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 5, 2026 | Exercise/Conversion | 233 | $12.95 | $3,017.35 | 233 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 5, 2026 | Sale | 233 | $228.18 | $53,165.94 | 0 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | May 4, 2026 | Exercise/Conversion | 4,517 | $0.00 | $0.00 | 115,187 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | May 5, 2026 | Exercise/Conversion | 233 | $0.00 | $0.00 | 114,954 | Direct | โ | View Details |